Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Coenzyme Q10 in Huntingtons Disease (HD).

Next Previous
X
Search
Trial Profile

Coenzyme Q10 in Huntingtons Disease (HD).

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 14 Mar 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ubidecarenone (Primary)
  • Indications Huntington's disease
  • Focus Therapeutic Use
  • Acronyms 2CARE

    • Most Recent Events

    • 08 Mar 2019 Results (n=609) related to suicidality are published in the Neurology
    • 02 Dec 2016 Primary endpoint (Joint Rank (Combination of Time to Death (for Subjects Who Died) and Change in Total Functional Capacity Score (TFC) From Baseline to Month 60 (for Subjects Who Survived) has not been met, according to results of an interim analysis for futility, published in the Neurology journal.
    • 02 Dec 2016 Results of an interim analysis for futility, published in the Neurology journal.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top